Bartosz Wasąg
University Clinical Centre(PL)Gdańsk Medical University(PL)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Lipoproteins and Cardiovascular Health, Renal cell carcinoma treatment, Gastrointestinal Tumor Research and Treatment
Most-Cited Works
- → Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants(2005)492 cited
- → Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group(2004)442 cited
- → Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity(2004)214 cited
- → Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)(2019)150 cited
- → Mutations in gastrointestinal stromal tumors – a population‐based study from Northern Norway(2007)130 cited
- → Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal Stromal Tumor–Associated PDGFRAD842V Mutation(2008)